Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT03638336
Other study ID # IDIL/2016/SD-01
Secondary ID
Status Withdrawn
Phase N/A
First received
Last updated
Start date October 2018
Est. completion date January 2020

Study information

Verified date August 2020
Source Centre Hospitalier Universitaire de Nimes
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

In this pilot study, we wish to evaluate the performance of a robotic flexible ureteorscopy (ILY) in the treatment of nephrolithiasis in the superior excretory system


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date January 2020
Est. primary completion date January 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- The patient must have given their free and informed consent and signed the consent form

- The patient must be a member or beneficiary of a health insurance plan

- The patient is at least 18 years old

- The patient has a single kidney stone in the calyx or the pelvis between 5 and 15mm something to do with a JJ probe

- Patient has an indication for in situ lithotripsy by supply ureteroscopy

Exclusion Criteria:

- The subject is participating in an interventional study, or is in a period of exclusion determined by a previous study

- The patient is under safeguard of justice or state guardianship

- The subject refuses to sign the consent

- It is impossible to give the subject informed information

- The patient is pregnant or breastfeeding

- Patient treated with anticoagulants

- Documented untreated urinary infection within the previous 48 hours

Study Design


Intervention

Device:
ILY robotic flexible ureteroscopy
fragmentation of nephrolithiasis

Locations

Country Name City State
France CHU Nimes Nîmes

Sponsors (1)

Lead Sponsor Collaborator
Centre Hospitalier Universitaire de Nimes

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of procedures performed entirely using the telemanipulator end of study: 3 months
Primary Number of procedures where the surgeon had to switch to manual mode or dedock the device end of study: 3 months
Primary If telemanipulator remained stable during procedure Yes/no end of procedure; less than 2 hours
Primary Time of procedure end of procedure; less than 2 hours
Primary Docking time time between docking of device and use of gamepad end of procedure; less than 2 hours
Primary Time taken to track kidney stones end of procedure; less than 2 hours
Primary Time taken for complete exploration of renal cavities end of procedure; less than 2 hours
Primary Laser fragmentation time end of procedure; less than 2 hours
Primary Speed of fragmentation mm3/minute end of procedure; less than 2 hours
Primary Any joint pain strain experienced by the surgeon before and after intervention binary yes/no end of procedure; less than 2 hours
Primary Satisfaction of surgeon in using the device Custom-made questionnaire with 3 sections measuring: ease of use, ergonomics in exploration of renal cavities and stability during fragmentation of laser end of procedure; less than 2 hours
Secondary Describe the rate of intra-operative complications during procedure end of procedure; less than 2 hours
Secondary Describe the rate of intra-operative complications 1 month
Secondary Integrity of the ureroscope at the end of the procedure binary yes/no end of procedure; less than 2 hours
See also
  Status Clinical Trial Phase
Completed NCT03512600 - Study of the Effects of the Consumption of Different Products Cocoa Derivatives at the Risk of Crystallization of Uric Acid in Urine of Volunteers. N/A
Recruiting NCT05593783 - The Use of the "Comprehensive Complication Index" for Urinary Lithiasis Surgery.